Schedule 13G ownership disclosure
ADAPTIMMUNE THERAPEUTICS PLC
Security class unavailable · CUSIP: 00653A107
Event date: 2016-11-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-777781
- Form type
- SC 13G
- Filer
- Aimmune Therapeutics, Inc.
- CIK
- CIK 1631650
- Filed
- Nov 28, 2016
- Reporting period
- Nov 23, 2016
- Description
- Schedule 13G beneficial ownership